CD8A and COVID-19: PGD2, an eicosanoid that exhibits some selectivity for sepsis due to COVID‐19, appears to exhibit a particular influence on non‐B non‐T cells and CD4+ T cells while the EC, AEA is linked to CD8 T cell activation.